- Home
- PCVX vs ORA Comparison
PCVX vs ORA Comparison
Compare PCVX & ORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- ORA
- Stock Information
- Founded
- PCVX 2013
- ORA 1965
- Country
- PCVX United States
- ORA United States
- Employees
- PCVX N/A
- ORA N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- ORA Electric Utilities: Central
- Sector
- PCVX Health Care
- ORA Utilities
- Exchange
- PCVX Nasdaq
- ORA Nasdaq
- Market Cap
- PCVX 4.5B
- ORA 4.4B
- IPO Year
- PCVX 2020
- ORA 2004
- Fundamental
- Price
- PCVX $31.16
- ORA $74.79
- Analyst Decision
- PCVX Strong Buy
- ORA Buy
- Analyst Count
- PCVX 10
- ORA 8
- Target Price
- PCVX $136.50
- ORA $85.13
- AVG Volume (30 Days)
- PCVX 2.2M
- ORA 413.4K
- Earning Date
- PCVX 05-07-2025
- ORA 05-07-2025
- Dividend Yield
- PCVX N/A
- ORA 0.64%
- EPS Growth
- PCVX N/A
- ORA N/A
- EPS
- PCVX N/A
- ORA 2.06
- Revenue
- PCVX N/A
- ORA $885,250,000.00
- Revenue This Year
- PCVX N/A
- ORA $9.27
- Revenue Next Year
- PCVX N/A
- ORA $13.71
- P/E Ratio
- PCVX N/A
- ORA $36.22
- Revenue Growth
- PCVX N/A
- ORA 1.95
- 52 Week Low
- PCVX $27.66
- ORA $61.58
- 52 Week High
- PCVX $121.06
- ORA $84.30
- Technical
- Relative Strength Index (RSI)
- PCVX 36.73
- ORA 63.54
- Support Level
- PCVX $28.09
- ORA $70.71
- Resistance Level
- PCVX $33.75
- ORA $76.77
- Average True Range (ATR)
- PCVX 2.54
- ORA 1.48
- MACD
- PCVX 1.12
- ORA 0.16
- Stochastic Oscillator
- PCVX 35.61
- ORA 67.33
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About ORA Ormat Technologies Inc.
Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.